美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Veradermics, Inc.

37.75

+20.75122.06%

盘后：36.50-1.2500-3.31%19:59 EST

成交量：332.19万

成交额：1.22亿

市值：12.59亿

市盈率：-0.45

高：40.01

开：34.00

低：32.00

收：17.00

52周最高：40.01

52周最低：32.00

股本：3,335.02万

流通股本：1,510.00万

量比：- -

换手率：22.00%

股息：- -

股息率：- -

每股收益(TTM):-83.0983

每股收益(LYR):-37.0495

净资产收益率：--

总资产收益率：--

市净率：-12.78

市盈率(LYR):-1.02

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

Veradermics, Inc.

交易所：

NYSE

成立时间：

2019

员工人数：

19

公司地址：

470 James Street,Suite 14,New Haven,Connecticut,United States

官网：

http://www.veradermics.com

邮编：

06513

电话：

传真：

- -

简介：

VeraDermics, Incorporated成立于2019年10月5日，最初位于德克萨斯州，后于2021年9月15日转换为特拉华州公司。这家由皮肤科医生创办的晚期临床阶段生物制药公司专注于开发针对普遍存在的美学和皮肤病状况的创新疗法。VeraDermics主要致力于解决影响美国众多个体的模式性脱发（PHL）治疗挑战。公司目前正在推进其主要候选药物VDPHL01，这是一种口服非激素治疗，旨在优化毛发生长，同时最小化与传统疗法相关的副作用。VeraDermics正在进行关键临床试验，以支持监管审批，并通过其针对性的治疗方法，旨在改变PHL的管理方式。

董事

名称

职位

Reid Waldman

Chief Executive Officer and Director

David Friedman

Independent Director

Jane Grant Kels

Independent Director

John W. Childs

Independent Director

Katarina Pance

Independent Director

Patrick Enright

Independent Director

Vlad Coric

Independent Director

股东

名称

职位

Reid Waldman

Chief Executive Officer and Director

Dominic Carrano

Chief Financial Officer

Mark Neumann

Chief Commercial and Strategy Officer

Michael V. Greco

General Counsel

Tim Durso

President

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/MANE/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MANE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MANE\",,,,,undefined,":{"symbol":"MANE","market":"US","secType":"STK","nameCN":"Veradermics, Inc.","latestPrice":37.75,"timestamp":1770238800000,"preClose":17,"halted":0,"volume":3321854,"hourTrading":{"tag":"盘后","latestPrice":36.5,"preClose":37.75,"latestTime":"19:59 EST","volume":62306,"amount":2345312.2133,"timestamp":1770253194262,"change":-1.25,"changeRate":-0.033113,"amplitude":0.057483},"delay":0,"changeRate":1.2205882352941178,"floatShares":15100000,"shares":33350170,"eps":-83.09831,"marketStatus":"已收盘","change":20.75,"latestTime":"02-04 16:00:00 EST","open":34,"high":40.01,"low":32,"amount":121647854.75138,"amplitude":0.471176,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-83.09831,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1770282000000},"marketStatusCode":5,"adr":0,"listingDate":1770181200000,"exchange":"NYSE","adjPreClose":17,"postHourTrading":{"tag":"盘后","latestPrice":36.5,"preClose":37.75,"latestTime":"19:59 EST","volume":62306,"amount":2345312.2133,"timestamp":1770253194262,"change":-1.25,"changeRate":-0.033113,"amplitude":0.057483},"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MANE\",,,,,undefined,":{"symbol":"MANE","floatShares":15100000,"roa":"--","roe":"--","lyrEps":-37.049501,"shares":33350170,"dividePrice":0,"high":40.01,"amplitude":0.471176,"preClose":17,"low":32,"week52Low":32,"pbRate":"-12.78","week52High":40.01,"institutionHeld":0,"latestPrice":37.75,"eps":-83.09831,"divideRate":0,"volume":3321854,"delay":0,"ttmEps":-83.09831,"open":34,"prevYearClose":17,"prevWeekClose":17,"prevMonthClose":17,"prevQuarterClose":17,"fiveDayClose":17,"twentyDayClose":17,"sixtyDayClose":17},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MANE\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MANE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MANE\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MANE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MANE","date":"2026-02-03","current":-0.45753,"percent":1,"low":-9.296992,"twenty":-9.296992,"median":-9.296992,"eighty":-9.296992,"high":-9.296992,"avg":-9.296992,"sd":0,"marketCap":500252550},"quantilePoints":[{"date":"2026-02-03","current":-9.296992,"twenty":-9.296992,"median":-9.296992,"eighty":-9.296992,"marketCap":500252550}],"updateTime":1770229892954},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":684321879,"yearFounded":2019,"employeeNum":19,"address":"470 James Street,Suite 14,New Haven,Connecticut,United States","zipCode":"06513","officePhone":"(228) 372-3376"},"stockCompanyDetail":{"websiteUrl":"http://www.veradermics.com","compareEarnings":[{"period":"1week","weight":-0.0086},{"period":"1month","weight":0.0093},{"period":"3month","weight":0.0176},{"period":"6month","weight":0.0906},{"period":"1year","weight":0.1535},{"period":"ytd","weight":0.0112}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"VeraDermics, Incorporated成立于2019年10月5日，最初位于德克萨斯州，后于2021年9月15日转换为特拉华州公司。这家由皮肤科医生创办的晚期临床阶段生物制药公司专注于开发针对普遍存在的美学和皮肤病状况的创新疗法。VeraDermics主要致力于解决影响美国众多个体的模式性脱发（PHL）治疗挑战。公司目前正在推进其主要候选药物VDPHL01，这是一种口服非激素治疗，旨在优化毛发生长，同时最小化与传统疗法相关的副作用。VeraDermics正在进行关键临床试验，以支持监管审批，并通过其针对性的治疗方法，旨在改变PHL的管理方式。","exchange":"NYSE","name":"Veradermics, Inc.","nameEN":"Veradermics, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"MANE\",market:\"US\",,,undefined,":{"directors":[{"name":"Reid Waldman","position":"Chief Executive Officer and Director"},{"name":"David Friedman","position":"Independent Director"},{"name":"Jane Grant Kels","position":"Independent Director"},{"name":"John W. Childs","position":"Independent Director"},{"name":"Katarina Pance","position":"Independent Director"},{"name":"Patrick Enright","position":"Independent Director"},{"name":"Vlad Coric","position":"Independent Director"}],"executives":[{"name":"Reid Waldman","position":"Chief Executive Officer and Director"},{"name":"Dominic Carrano","position":"Chief Financial Officer"},{"name":"Mark Neumann","position":"Chief Commercial and Strategy Officer"},{"name":"Michael V. Greco","position":"General Counsel"},{"name":"Tim Durso","position":"President"}]}}}